Associate Professor Antony Cooper
Associate Professor Antony Cooper is a cell and molecular biologist/geneticist with strong interests in elucidating how cellular dysfunction results in human diseases, with a specific interest in neurodegenerative disease such as Parkinson’s Disease. His research on neurodegenerative diseases focuses on understanding the basis of Parkinson’s disease. Antony completed a PhD at McGill University working on membrane trafficking, and post-doctoral studies at the University of Oregon involving both protein splicing and proteostasis/protein quality control in the endoplasmic reticulum (ER). As an Assistant Professor at the University of Missouri his interests evolved to protein misfolding, ER stress and oxidative stress, factors common to many neurodegenerative diseases. As a tenured Associate Professor in Missouri and since returning to Australia at the Garvan Institute of Medical Research he has focused his research on Parkinson’s disease.
- 2023Scientific reports10.1038/s41598-023-32480-0
Evaluation of plasma levels of NFL, GFAP, UCHL1 and tau as Parkinson's disease biomarkers using multiplexed single molecule counting.
- 2022ACS chemical neuroscience10.1021/acschemneuro.1c00553
Single Molecule Fingerprinting Reveals Different Amplification Properties of α-Synuclein Oligomers and Preformed Fibrils in Seeding Assay.
- 2022Genes & diseases10.1016/j.gendis.2021.12.015
Parkinson's disease: From genetics to molecular dysfunction and targeted therapeutic approaches.
- 2020Movement disorders : official journal of the Movement Disorder Society10.1002/mds.28144
Common Variants Coregulate Expression of GBA and Modifier Genes to Delay Parkinson's Disease Onset.
- 2015Movement disorders : official journal of the Movement Disorder Society10.1002/mds.26141
Lysosomal-associated membrane protein 2 isoforms are differentially affected in early Parkinson's disease.